Acura Pharmaceuticals, Inc. (ACUR)
Develops abuse-resistant pain and cold medications to prevent drug misuse.
$0.00-0.67%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-80.0%
The outlook
ACUR is trading at its 52-week low with minimal analyst coverage. The stock sits well below both its 50- and 200-day moving averages, reflecting a sustained downtrend. Current sentiment leans decidedly bearish based on available market data.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$6,600
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—